Morgan Stanley 13D and 13G filings for AxoGen, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-03 3:33 pm Sale |
2024-12-31 | 13G | AxoGen, Inc. AXGN |
MORGAN STANLEY MS |
2,330,406 5.300% |
-529,015 (-18.50%) |
Filing |
| 2024-02-12 1:21 pm Purchase |
2023-12-31 | 13G | AxoGen, Inc. AXGN |
MORGAN STANLEY MS |
2,859,421 6.600% |
2,859,421 (New Position) |
Filing |